APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nuclear Medicine Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nuclear Medicine Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchNuclear Medicine Therapy Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Nuclear Medicine Therapy Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Nuclear Medicine Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nuclear Medicine Therapy Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Nuclear Medicine Therapy Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Nuclear Medicine Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Nuclear Medicine Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nuclear Medicine Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nuclear Medicine Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nuclear Medicine Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nuclear Medicine Therapy include Aurobindo Pharma, China Isotope & Radiation, Curium Pharmaceuticals, International Isotopes, Jubilant Radiopharma, Lantheus, Mundipharma, Q BioMed and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Nuclear Medicine Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nuclear Medicine Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nuclear Medicine Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nuclear Medicine Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Nuclear Medicine Therapy Segment by Company

Aurobindo Pharma

China Isotope & Radiation

Curium Pharmaceuticals

International Isotopes

Jubilant Radiopharma

Lantheus

Mundipharma

Q BioMed

Bayer

Dongcheng

Novartis

Nuclear Medicine Therapy Segment by Type

Lutetium-177

Radium-223

Iodine-131

Other

Nuclear Medicine Therapy Segment by Application

Bone Metastasis

Thyroid

Lymphoma

Other

Nuclear Medicine Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nuclear Medicine Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nuclear Medicine Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nuclear Medicine Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nuclear Medicine Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nuclear Medicine Therapy industry.

Chapter 3: Detailed analysis of Nuclear Medicine Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Medicine Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nuclear Medicine Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Lutetium-177 Table 3. Key Players of Radium-223 Table 4. Key Players of Iodine-131 Table 3. Key Players of Other Table 4. Global Nuclear Medicine Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Bone Metastasis Table 6. Key Players of Thyroid Table 7. Key Players of Lymphoma Table 8. Key Players of Other Table 9. Global Nuclear Medicine Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Nuclear Medicine Therapy Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Nuclear Medicine Therapy Market Share by Region (2021-2026) Table 12. Global Nuclear Medicine Therapy Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Nuclear Medicine Therapy Market Share by Region (2027-2032) Table 14. Nuclear Medicine Therapy Industry Trends Table 15. Nuclear Medicine Therapy Industry Drivers Table 16. Nuclear Medicine Therapy Industry Opportunities and Challenges Table 17. Nuclear Medicine Therapy Industry Restraints Table 18. Global Nuclear Medicine Therapy Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Nuclear Medicine Therapy Revenue Market Share by Company (2021-2026) Table 20. Global Nuclear Medicine Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Nuclear Medicine Therapy Key Company Head Office and Area Served Table 22. Global Nuclear Medicine Therapy Company, Product Type & Application Table 23. Global Nuclear Medicine Therapy Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Nuclear Medicine Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Nuclear Medicine Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nuclear Medicine Therapy Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Nuclear Medicine Therapy Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Nuclear Medicine Therapy Revenue Market Share by Type (2021-2026) Table 30. Global Nuclear Medicine Therapy Revenue Market Share by Type (2027-2032) Table 31. Global Nuclear Medicine Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nuclear Medicine Therapy Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Nuclear Medicine Therapy Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Nuclear Medicine Therapy Revenue Market Share by Application (2021-2026) Table 35. Global Nuclear Medicine Therapy Revenue Market Share by Application (2027-2032) Table 36. Aurobindo Pharma Company Information Table 37. Aurobindo Pharma Business Overview Table 38. Aurobindo Pharma Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Aurobindo Pharma Nuclear Medicine Therapy Product Portfolio Table 40. Aurobindo Pharma Recent Development Table 41. China Isotope & Radiation Company Information Table 42. China Isotope & Radiation Business Overview Table 43. China Isotope & Radiation Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. China Isotope & Radiation Nuclear Medicine Therapy Product Portfolio Table 45. China Isotope & Radiation Recent Development Table 46. Curium Pharmaceuticals Company Information Table 47. Curium Pharmaceuticals Business Overview Table 48. Curium Pharmaceuticals Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Curium Pharmaceuticals Nuclear Medicine Therapy Product Portfolio Table 50. Curium Pharmaceuticals Recent Development Table 51. International Isotopes Company Information Table 52. International Isotopes Business Overview Table 53. International Isotopes Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. International Isotopes Nuclear Medicine Therapy Product Portfolio Table 55. International Isotopes Recent Development Table 56. Jubilant Radiopharma Company Information Table 57. Jubilant Radiopharma Business Overview Table 58. Jubilant Radiopharma Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Jubilant Radiopharma Nuclear Medicine Therapy Product Portfolio Table 60. Jubilant Radiopharma Recent Development Table 61. Lantheus Company Information Table 62. Lantheus Business Overview Table 63. Lantheus Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Lantheus Nuclear Medicine Therapy Product Portfolio Table 65. Lantheus Recent Development Table 66. Mundipharma Company Information Table 67. Mundipharma Business Overview Table 68. Mundipharma Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Mundipharma Nuclear Medicine Therapy Product Portfolio Table 70. Mundipharma Recent Development Table 71. Q BioMed Company Information Table 72. Q BioMed Business Overview Table 73. Q BioMed Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Q BioMed Nuclear Medicine Therapy Product Portfolio Table 75. Q BioMed Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Bayer Nuclear Medicine Therapy Product Portfolio Table 80. Bayer Recent Development Table 81. Dongcheng Company Information Table 82. Dongcheng Business Overview Table 83. Dongcheng Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Dongcheng Nuclear Medicine Therapy Product Portfolio Table 85. Dongcheng Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Novartis Nuclear Medicine Therapy Product Portfolio Table 90. Novartis Recent Development Table 91. North America Nuclear Medicine Therapy Market Size by Type (2021-2026) & (US$ Million) Table 92. North America Nuclear Medicine Therapy Market Size by Type (2027-2032) & (US$ Million) Table 93. North America Nuclear Medicine Therapy Market Size by Application (2021-2026) & (US$ Million) Table 94. North America Nuclear Medicine Therapy Market Size by Application (2027-2032) & (US$ Million) Table 95. North America Nuclear Medicine Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Nuclear Medicine Therapy Market Size by Country (2021-2026) Table 97. North America Nuclear Medicine Therapy Market Size by Country (2027-2032) Table 98. Europe Nuclear Medicine Therapy Market Size by Type (2021-2026) & (US$ Million) Table 99. Europe Nuclear Medicine Therapy Market Size by Type (2027-2032) & (US$ Million) Table 100. Europe Nuclear Medicine Therapy Market Size by Application (2021-2026) & (US$ Million) Table 101. Europe Nuclear Medicine Therapy Market Size by Application (2027-2032) & (US$ Million) Table 102. Europe Nuclear Medicine Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Nuclear Medicine Therapy Market Size by Country (2021-2026) Table 104. Europe Nuclear Medicine Therapy Market Size by Country (2027-2032) Table 105. China Nuclear Medicine Therapy Market Size by Type (2021-2026) & (US$ Million) Table 106. China Nuclear Medicine Therapy Market Size by Type (2027-2032) & (US$ Million) Table 107. China Nuclear Medicine Therapy Market Size by Application (2021-2026) & (US$ Million) Table 108. China Nuclear Medicine Therapy Market Size by Application (2027-2032) & (US$ Million) Table 109. Asia Nuclear Medicine Therapy Market Size by Type (2021-2026) & (US$ Million) Table 110. Asia Nuclear Medicine Therapy Market Size by Type (2027-2032) & (US$ Million) Table 111. Asia Nuclear Medicine Therapy Market Size by Application (2021-2026) & (US$ Million) Table 112. Asia Nuclear Medicine Therapy Market Size by Application (2027-2032) & (US$ Million) Table 113. Asia Nuclear Medicine Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Nuclear Medicine Therapy Market Size by Country (2021-2026) Table 115. Asia Nuclear Medicine Therapy Market Size by Country (2027-2032) Table 116. South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Type (2021-2026) & (US$ Million) Table 117. South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Type (2027-2032) & (US$ Million) Table 118. South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Application (2021-2026) & (US$ Million) Table 119. South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Application (2027-2032) & (US$ Million) Table 120. South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2021-2026) Table 122. South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Nuclear Medicine Therapy Product Image Figure 2. Global Nuclear Medicine Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Nuclear Medicine Therapy Market Share by Type: 2025 VS 2032 Figure 4. Lutetium-177 Image Figure 5. Radium-223 Image Figure 6. Iodine-131 Image Figure 7. Other Image Figure 8. Global Nuclear Medicine Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Nuclear Medicine Therapy Market Share by Application: 2025 VS 2032 Figure 10. Bone Metastasis Image Figure 11. Thyroid Image Figure 12. Lymphoma Image Figure 13. Other Image Figure 14. Global Nuclear Medicine Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 16. Global Nuclear Medicine Therapy Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Nuclear Medicine Therapy Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Nuclear Medicine Therapy Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Nuclear Medicine Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Nuclear Medicine Therapy Revenue Market Share by Type (2021-2032) Figure 23. Global Nuclear Medicine Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nuclear Medicine Therapy Revenue Market Share by Application (2021-2032) Figure 25. North America Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 26. North America Nuclear Medicine Therapy Market Share by Type (2021-2032) Figure 27. North America Nuclear Medicine Therapy Market Share by Application (2021-2032) Figure 28. North America Nuclear Medicine Therapy Market Share by Country (2021-2032) Figure 29. United States Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 30. Canada Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 32. Europe Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 33. Europe Nuclear Medicine Therapy Market Share by Type (2021-2032) Figure 34. Europe Nuclear Medicine Therapy Market Share by Application (2021-2032) Figure 35. Europe Nuclear Medicine Therapy Market Share by Country (2021-2032) Figure 36. Germany Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 37. France Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 39. Italy Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 40. Russia Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 42. China Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 43. China Nuclear Medicine Therapy Market Share by Type (2021-2032) Figure 44. China Nuclear Medicine Therapy Market Share by Application (2021-2032) Figure 45. Asia Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 46. Asia Nuclear Medicine Therapy Market Share by Type (2021-2032) Figure 47. Asia Nuclear Medicine Therapy Market Share by Application (2021-2032) Figure 48. Asia Nuclear Medicine Therapy Market Share by Country (2021-2032) Figure 49. Japan Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 53. India Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 54. Australia Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Nuclear Medicine Therapy Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Nuclear Medicine Therapy Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Nuclear Medicine Therapy Market Share by Country (2021-2032) Figure 59. Brazil Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 64. UAE Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 66. Chile Nuclear Medicine Therapy Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Lutetium-177
  • Radium-223
  • Iodine-131
  • Other
Applications
  • Bone Metastasis
  • Thyroid
  • Lymphoma
  • Other
Companies covered
  • Aurobindo Pharma
  • China Isotope & Radiation
  • Curium Pharmaceuticals
  • International Isotopes
  • Jubilant Radiopharma
  • Lantheus
  • Mundipharma
  • Q BioMed
  • Bayer
  • Dongcheng
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Nuclear Medicine Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Lutetium-177
  5. 1.2.3 Radium-223
  6. 1.2.4 Iodine-131
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Nuclear Medicine Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Bone Metastasis
  11. 1.3.3 Thyroid
  12. 1.3.4 Lymphoma
  13. 1.3.5 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Nuclear Medicine Therapy Growth Trends by Region
  16. 1.5.1 Global Nuclear Medicine Therapy Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Nuclear Medicine Therapy Market Size by Region (2021-2026)
  18. 1.5.3 Nuclear Medicine Therapy Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Nuclear Medicine Therapy Market Dynamics
  1. 2.1 Nuclear Medicine Therapy Industry Trends
  2. 2.2 Nuclear Medicine Therapy Industry Drivers
  3. 2.3 Nuclear Medicine Therapy Industry Opportunities and Challenges
  4. 2.4 Nuclear Medicine Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Nuclear Medicine Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Nuclear Medicine Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Nuclear Medicine Therapy Key Company Head office and Area Served
  4. 3.4 Global Nuclear Medicine Therapy Company, Product Type & Application
  5. 3.5 Global Nuclear Medicine Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Nuclear Medicine Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Nuclear Medicine Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Nuclear Medicine Therapy Tier 1, Tier 2, and Tier 3
4 Nuclear Medicine Therapy Market by Type
  1. 4.1 Global Nuclear Medicine Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Nuclear Medicine Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Nuclear Medicine Therapy Market Size Share by Type (2021-2032)
5 Nuclear Medicine Therapy Market by Application
  1. 5.1 Global Nuclear Medicine Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Nuclear Medicine Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Nuclear Medicine Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Aurobindo Pharma
  2. 6.1.1 Aurobindo Pharma Company Information
  3. 6.1.2 Aurobindo Pharma Business Overview
  4. 6.1.3 Aurobindo Pharma Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Aurobindo Pharma Nuclear Medicine Therapy Product Portfolio
  6. 6.1.5 Aurobindo Pharma Recent Developments
  7. 6.2 China Isotope & Radiation
  8. 6.2.1 China Isotope & Radiation Company Information
  9. 6.2.2 China Isotope & Radiation Business Overview
  10. 6.2.3 China Isotope & Radiation Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 China Isotope & Radiation Nuclear Medicine Therapy Product Portfolio
  12. 6.2.5 China Isotope & Radiation Recent Developments
  13. 6.3 Curium Pharmaceuticals
  14. 6.3.1 Curium Pharmaceuticals Company Information
  15. 6.3.2 Curium Pharmaceuticals Business Overview
  16. 6.3.3 Curium Pharmaceuticals Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Curium Pharmaceuticals Nuclear Medicine Therapy Product Portfolio
  18. 6.3.5 Curium Pharmaceuticals Recent Developments
  19. 6.4 International Isotopes
  20. 6.4.1 International Isotopes Company Information
  21. 6.4.2 International Isotopes Business Overview
  22. 6.4.3 International Isotopes Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 International Isotopes Nuclear Medicine Therapy Product Portfolio
  24. 6.4.5 International Isotopes Recent Developments
  25. 6.5 Jubilant Radiopharma
  26. 6.5.1 Jubilant Radiopharma Company Information
  27. 6.5.2 Jubilant Radiopharma Business Overview
  28. 6.5.3 Jubilant Radiopharma Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Jubilant Radiopharma Nuclear Medicine Therapy Product Portfolio
  30. 6.5.5 Jubilant Radiopharma Recent Developments
  31. 6.6 Lantheus
  32. 6.6.1 Lantheus Company Information
  33. 6.6.2 Lantheus Business Overview
  34. 6.6.3 Lantheus Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Lantheus Nuclear Medicine Therapy Product Portfolio
  36. 6.6.5 Lantheus Recent Developments
  37. 6.7 Mundipharma
  38. 6.7.1 Mundipharma Company Information
  39. 6.7.2 Mundipharma Business Overview
  40. 6.7.3 Mundipharma Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Mundipharma Nuclear Medicine Therapy Product Portfolio
  42. 6.7.5 Mundipharma Recent Developments
  43. 6.8 Q BioMed
  44. 6.8.1 Q BioMed Company Information
  45. 6.8.2 Q BioMed Business Overview
  46. 6.8.3 Q BioMed Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Q BioMed Nuclear Medicine Therapy Product Portfolio
  48. 6.8.5 Q BioMed Recent Developments
  49. 6.9 Bayer
  50. 6.9.1 Bayer Company Information
  51. 6.9.2 Bayer Business Overview
  52. 6.9.3 Bayer Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Bayer Nuclear Medicine Therapy Product Portfolio
  54. 6.9.5 Bayer Recent Developments
  55. 6.10 Dongcheng
  56. 6.10.1 Dongcheng Company Information
  57. 6.10.2 Dongcheng Business Overview
  58. 6.10.3 Dongcheng Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Dongcheng Nuclear Medicine Therapy Product Portfolio
  60. 6.10.5 Dongcheng Recent Developments
  61. 6.11 Novartis
  62. 6.11.1 Novartis Company Information
  63. 6.11.2 Novartis Business Overview
  64. 6.11.3 Novartis Nuclear Medicine Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Novartis Nuclear Medicine Therapy Product Portfolio
  66. 6.11.5 Novartis Recent Developments
7 North America
  1. 7.1 North America Nuclear Medicine Therapy Market Size (2021-2032)
  2. 7.2 North America Nuclear Medicine Therapy Market Size by Type
  3. 7.2.1 North America Nuclear Medicine Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Nuclear Medicine Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Nuclear Medicine Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Nuclear Medicine Therapy Market Size by Application
  7. 7.3.1 North America Nuclear Medicine Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Nuclear Medicine Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Nuclear Medicine Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Nuclear Medicine Therapy Market Size by Country
  11. 7.4.1 North America Nuclear Medicine Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Nuclear Medicine Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Nuclear Medicine Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Nuclear Medicine Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Nuclear Medicine Therapy Market Size (2021-2032)
  2. 8.2 Europe Nuclear Medicine Therapy Market Size by Type
  3. 8.2.1 Europe Nuclear Medicine Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Nuclear Medicine Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Nuclear Medicine Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Nuclear Medicine Therapy Market Size by Application
  7. 8.3.1 Europe Nuclear Medicine Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Nuclear Medicine Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Nuclear Medicine Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Nuclear Medicine Therapy Market Size by Country
  11. 8.4.1 Europe Nuclear Medicine Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Nuclear Medicine Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Nuclear Medicine Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Nuclear Medicine Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Nuclear Medicine Therapy Market Size (2021-2032)
  2. 9.2 China Nuclear Medicine Therapy Market Size by Type
  3. 9.2.1 China Nuclear Medicine Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Nuclear Medicine Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Nuclear Medicine Therapy Market Share by Type (2021-2032)
  6. 9.3 China Nuclear Medicine Therapy Market Size by Application
  7. 9.3.1 China Nuclear Medicine Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Nuclear Medicine Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Nuclear Medicine Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Nuclear Medicine Therapy Market Size (2021-2032)
  2. 10.2 Asia Nuclear Medicine Therapy Market Size by Type
  3. 10.2.1 Asia Nuclear Medicine Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Nuclear Medicine Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Nuclear Medicine Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Nuclear Medicine Therapy Market Size by Application
  7. 10.3.1 Asia Nuclear Medicine Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Nuclear Medicine Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Nuclear Medicine Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Nuclear Medicine Therapy Market Size by Country
  11. 10.4.1 Asia Nuclear Medicine Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Nuclear Medicine Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Nuclear Medicine Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Nuclear Medicine Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Nuclear Medicine Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Nuclear Medicine Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Nuclear Medicine Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Nuclear Medicine Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst